Literature DB >> 25577276

Laparoscopic ventral rectopexy using biologic mesh for the treatment of obstructed defaecation syndrome and/or faecal incontinence in patients with internal rectal prolapse: a critical appraisal of the first 100 cases.

L Franceschilli1, D Varvaras, I Capuano, C I Ciangola, F Giorgi, G Boehm, A L Gaspari, P Sileri.   

Abstract

BACKGROUND: Laparoscopic ventral mesh rectopexy (LVR) is gaining wider acceptance as the preferred procedure to correct internal as well as external rectal prolapse associated with obstructed defaecation syndrome and/or faecal incontinence. Very few reports exist on the use of biologic mesh for LVR. The aim of our study was to report the complication and recurrence rate of our first 100 cases of LVR for symptomatic internal rectal prolapse and/or rectocele using a porcine dermal collagen mesh.
METHODS: Prospectively collected data on LVR for internal rectal prolapse were analysed. Surgical complications and functional results in terms of faecal incontinence (measured with the Faecal Incontinence Severity Index = FISI) and constipation (measured with the Wexner Constipation Score = WCS) at 3, 6 and 12 months were analysed. It was considered an improvement if FISI or WCS scores were reduced by at least 25 % and a cure if the FISI score decreased to <10 and the WCS decreased to <5.
RESULTS: Between April 2009 and April 2013, 100 consecutive female patients (mean age 63 years, range 24-88 years) underwent LVR. All patients had internal rectal prolapse (grade III [n = 25] and grade IV [n = 75] according to the Oxford classification) and rectocele. Mean operative time was 85 ± 40 min. Conversion rate to open technique was 1 %. There was no post-operative mortality. Overall 16 patients (16 %) experienced 18 complications, including rectal perforation (n = 1), small bowel obstruction (n = 2), urinary tract infection (n = 8), subcutaneous emphysema (n = 3), wound haematoma (n = 2), long lasting sacral pain (n = 1) and incisional hernia (1). Median post-operative length of stay was 2 days. Ninety-eight out of 100 patients completed follow-up. At the end of follow-up, the mean FISI score improved from 8.4 (±4.0 standard deviation (SD) p = 0.003) to 3.3 ± 2.3 SD (p = 0.04). Incontinence improved in 37 out of 43 patients (86 %), and 31 patients (72 %) were cured. Similarly, the mean WCS score improved from 18.4 ± 11.6 SD to 5.4 ± 4.1 SD (p = 0.04). Constipation improved in 82 out of 89 patients (92 %), and 70 patients (79 %) were cured. No worsening of continence status, constipation or sexual function was observed. Fourteen patients (14 %) experienced persistence or recurrence of prolapse.
CONCLUSIONS: LVR using biologic mesh is a safe and effective procedure for improving symptoms of obstructed defaecation and faecal incontinence in patients with internal rectal prolapse associated with rectocele.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25577276     DOI: 10.1007/s10151-014-1255-4

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN: 1123-6337            Impact factor:   3.781


  40 in total

1.  Laparoscopic ventral recto(colpo)pexy for rectal prolapse: surgical technique and outcome for 109 patients.

Authors:  A D'Hoore; F Penninckx
Journal:  Surg Endosc       Date:  2006-12       Impact factor: 4.584

2.  Surgical treatment of rectal prolapse. A retrospective analysis of 94 cases.

Authors:  M Yakut; N Kaymakçioğlu; A Simşek; A Tan; D Sen
Journal:  Int Surg       Date:  1998 Jan-Mar

3.  The risk of infection of three synthetic materials used in rectopexy with or without colonic resection for rectal prolapse.

Authors:  S Athanasiadis; G Weyand; J Heiligers; L Heumuller; L Barthelmes
Journal:  Int J Colorectal Dis       Date:  1996       Impact factor: 2.571

4.  Technical and functional results after laparoscopic rectopexy to the promontory for complete rectal prolapse. Prospective study in 54 consecutive patients.

Authors:  Thomas Auguste; Alain Dubreuil; Richard Bost; Bruno Bonaz; Jean-Luc Faucheron
Journal:  Gastroenterol Clin Biol       Date:  2006-05

5.  Perineal proctectomy, posterior rectopexy, and postanal levator repair for the treatment of rectal prolapse.

Authors:  M L Prasad; R K Pearl; H Abcarian; C P Orsay; R L Nelson
Journal:  Dis Colon Rectum       Date:  1986-09       Impact factor: 4.585

6.  Laparoscopic ventral rectopexy for internal rectal prolapse using biological mesh: postoperative and short-term functional results.

Authors:  Pierpaolo Sileri; Luana Franceschilli; Elisabetta de Luca; Sara Lazzaro; Giulio P Angelucci; Valeria Fiaschetti; Carolina Pasecenic; Achille L Gaspari
Journal:  J Gastrointest Surg       Date:  2012-01-07       Impact factor: 3.452

7.  Long-term outcome of laparoscopic ventral rectopexy for total rectal prolapse.

Authors:  A D'Hoore; R Cadoni; F Penninckx
Journal:  Br J Surg       Date:  2004-11       Impact factor: 6.939

8.  How to deal with complications after laparoscopic ventral mesh rectopexy: lessons learnt from a tertiary referral centre.

Authors:  A H Badrek-Al Amoudi; G L Greenslade; A R Dixon
Journal:  Colorectal Dis       Date:  2013-06       Impact factor: 3.788

9.  Laparoscopic ventral rectopexy for rectal prolapse and symptomatic rectocele: an analysis of 245 consecutive patients.

Authors:  H A Formijne Jonkers; N Poierrié; W A Draaisma; I A M J Broeders; E C J Consten
Journal:  Colorectal Dis       Date:  2013-06       Impact factor: 3.788

10.  Functional outcome after transperineal rectocele repair with porcine dermal collagen implant.

Authors:  Neil J Smart; Mark A Mercer-Jones
Journal:  Dis Colon Rectum       Date:  2007-09       Impact factor: 4.585

View more
  22 in total

Review 1.  [Complications after rectal prolapse surgery].

Authors:  T H K Schiedeck
Journal:  Chirurg       Date:  2015-08       Impact factor: 0.955

2.  Descending perineum syndrome: new perspectives.

Authors:  F Pucciani
Journal:  Tech Coloproctol       Date:  2015-06-06       Impact factor: 3.781

3.  Lumbosacral discitis following laparoscopic ventral mesh rectopexy: a rare but potentially serious complication.

Authors:  Z Vujovic; E Cuarana; K L Campbell; N Valentine; S Koch; D Ziyaie
Journal:  Tech Coloproctol       Date:  2015-02-28       Impact factor: 3.781

4.  Biological mesh extrusion months after laparoscopic ventral rectopexy.

Authors:  P Sileri; M Shalaby; A Orlandi
Journal:  Tech Coloproctol       Date:  2016-11-24       Impact factor: 3.781

Review 5.  Functional Disorders of Constipation: Paradoxical Puborectalis Contraction and Increased Perineal Descent.

Authors:  Isaac Payne; Leander M Grimm
Journal:  Clin Colon Rectal Surg       Date:  2017-02

Review 6.  Current status of laparoscopic and robotic ventral mesh rectopexy for external and internal rectal prolapse.

Authors:  Jan J van Iersel; Tim J C Paulides; Paul M Verheijen; John W Lumley; Ivo A M J Broeders; Esther C J Consten
Journal:  World J Gastroenterol       Date:  2016-06-07       Impact factor: 5.742

7.  Pelvic floor function following ventral rectopexy versus STARR in the treatment of obstructed defecation.

Authors:  D F Altomare; A Picciariello; R Memeo; M Fanelli; R Digennaro; N Chetta; M De Fazio
Journal:  Tech Coloproctol       Date:  2018-03-28       Impact factor: 3.781

8.  Advantages of robotic surgery in the treatment of complex pelvic organs prolapse.

Authors:  Gabriele Naldini; Bernardina Fabiani; Alessandro Sturiale; Eleonora Russo; Tommaso Simoncini
Journal:  Updates Surg       Date:  2021-01-02

9.  Anatomo-functional outcomes of the laparoscopic Frykman-Goldberg procedure for rectal prolapse in a tertiary referral centre.

Authors:  Gaetano Gallo; Mario Trompetto; Alberto Realis Luc; Giuseppe Clerico; Giuseppe Sammarco; Eugenio Novelli; Gilda De Paola
Journal:  Updates Surg       Date:  2021-06-17

10.  Anatomical and functional changes to the pelvic floor after robotic versus laparoscopic ventral rectopexy: a randomised study.

Authors:  Johanna K Mäkelä-Kaikkonen; Tero T Rautio; Sari Koivurova; Eija Pääkkö; Pasi Ohtonen; Fausto Biancari; Jyrki T Mäkelä
Journal:  Int Urogynecol J       Date:  2016-06-01       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.